MPLX Q2: A Soft-Looking Quarter That Quietly De-Risked The Thesis

MPLX (MPLX) remains a Strong Buy, with reliable income and visible growth supported by robust project execution and strong demand. Distribution coverage remains healthy at ~1.3x, with a 12.5% distribution growth commitment now extended through 2026 and 2027. Recent distributable cash flow softness is attributed to timing and financing of growth projects, not structural weakness, with leverage at a manageable ~3.7x. Growth projects are on schedule or ahead, with high asset utilization and strong demand, shifting the thesis from rerating to income compounding.

When I rated MPLX ( MPLX ) a Strong Buy in March, the core reason was reliable income and visible growth. The latest quarterly results look soft on the surface as distributable cash